Article
A pilot study of ADRA2A genotype association with doses of dexmedetomidine for sedation in pediatric patients.
Pharmacotherapy - 1 Jun 2022
Gallaway Katherine A, Skaar Todd C, Biju Ashwin, Slaven James, Tillman Emma M
Abstract excerpt
STUDY OBJECTIVE: Dexmedetomidine is titrated to achieve sedation in the pediatric and cardiovascular intensive care units (PICU and CVICU). In adults, dexmedetomidine response has been associated with an ADRA2A polymorphism (rs1800544); CC genotype is associated with an increased sedative response compared with GC and GG. To date, this has not been studied in children. DESIGN: We conducted a pilot study to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
